Holen Sie sich die Stockscreener-App
172.61
0.61%
1.05
Handel nachbörslich:
172.61
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt ABBV?
Forum
Prognose
Dividendenhistorie
Schlusskurs vom Vortag:
$171.56
Offen:
$172.16
24-Stunden-Volumen:
7.06M
Relative Volume:
1.23
Marktkapitalisierung:
$305.03B
Einnahmen:
$55.53B
Nettoeinkommen (Verlust:
$5.12B
KGV:
59.93
EPS:
2.88
Netto-Cashflow:
$15.62B
1W Leistung:
-1.67%
1M Leistung:
-1.69%
6M Leistung:
+0.17%
1J Leistung:
+4.76%
1-Tages-Spanne:
$171.22
$175.66
1-Wochen-Bereich:
$168.72
$175.66
52-Wochen-Spanne:
$153.58
$207.32
Abbvie Inc Stock (ABBV) Company Profile
Firmenname
Abbvie Inc
Sektor
Telefon
(847) 932-7900
Adresse
1 NORTH WAUKEGAN ROAD, NORTH CHICAGO, IL
Vergleichen Sie ABBV mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
ABBV
Abbvie Inc
|
172.61 | 305.03B | 55.53B | 5.12B | 15.62B | 2.88 |
|
LLY
Lilly Eli Co
|
742.35 | 705.53B | 40.86B | 8.37B | -2.28B | 9.25 |
|
NVO
Novo Nordisk Adr
|
81.03 | 359.79B | 39.36B | 13.79B | 9.83B | 3.086 |
|
JNJ
Johnson Johnson
|
148.15 | 344.63B | 87.70B | 14.68B | 19.03B | 6.05 |
|
MRK
Merck Co Inc
|
96.24 | 251.88B | 63.17B | 12.15B | 14.84B | 4.77 |
Abbvie Inc Stock (ABBV) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-10 | Fortgesetzt | BofA Securities | Neutral |
| 2024-12-05 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2024-11-22 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2024-11-15 | Eingeleitet | Wolfe Research | Outperform |
| 2024-11-04 | Hochstufung | Argus | Hold → Buy |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-06-05 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-05-17 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-01-29 | Hochstufung | William Blair | Mkt Perform → Outperform |
| 2023-12-18 | Herabstufung | HSBC Securities | Buy → Hold |
| 2023-12-11 | Hochstufung | Goldman | Neutral → Buy |
| 2023-11-09 | Eingeleitet | Deutsche Bank | Hold |
| 2023-10-30 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2023-10-20 | Fortgesetzt | UBS | Neutral |
| 2023-09-29 | Eingeleitet | Raymond James | Outperform |
| 2023-07-25 | Eingeleitet | William Blair | Mkt Perform |
| 2023-07-14 | Eingeleitet | HSBC Securities | Buy |
| 2023-04-05 | Herabstufung | Argus | Buy → Hold |
| 2023-03-01 | Eingeleitet | Guggenheim | Buy |
| 2023-02-22 | Herabstufung | Wolfe Research | Outperform → Peer Perform |
| 2023-02-10 | Hochstufung | SVB Securities | Underperform → Market Perform |
| 2022-11-18 | Eingeleitet | Credit Suisse | Outperform |
| 2022-11-08 | Herabstufung | Societe Generale | Buy → Hold |
| 2022-08-01 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-05-23 | Eingeleitet | SVB Leerink | Underperform |
| 2022-05-06 | Herabstufung | Daiwa Securities | Outperform → Neutral |
| 2022-04-06 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-02-28 | Herabstufung | UBS | Buy → Neutral |
| 2022-02-03 | Bestätigt | BMO Capital Markets | Outperform |
| 2022-02-03 | Bestätigt | Barclays | Equal Weight |
| 2022-02-03 | Bestätigt | BofA Securities | Neutral |
| 2022-02-03 | Bestätigt | Goldman | Neutral |
| 2022-01-13 | Eingeleitet | Redburn | Buy |
| 2022-01-12 | Bestätigt | BMO Capital Markets | Outperform |
| 2021-12-09 | Fortgesetzt | Wells Fargo | Overweight |
| 2021-11-23 | Hochstufung | Societe Generale | Hold → Buy |
| 2021-07-27 | Fortgesetzt | Truist | Buy |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2020-11-10 | Fortgesetzt | Bernstein | Outperform |
| 2020-09-29 | Eingeleitet | Berenberg | Hold |
| 2020-06-23 | Hochstufung | Atlantic Equities | Neutral → Overweight |
| 2020-06-09 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2020-06-02 | Hochstufung | Argus | Hold → Buy |
| 2020-05-18 | Fortgesetzt | BofA/Merrill | Neutral |
| 2020-05-12 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-05-11 | Fortgesetzt | Morgan Stanley | Overweight |
| 2020-04-20 | Hochstufung | RBC Capital Mkts | Sector Perform → Outperform |
| 2020-03-23 | Herabstufung | Societe Generale | Buy → Hold |
| 2020-02-27 | Eingeleitet | Barclays | Equal Weight |
| 2020-02-06 | Eingeleitet | Mizuho | Buy |
| 2020-01-07 | Eingeleitet | RBC Capital Mkts | Sector Perform |
| 2019-12-26 | Bestätigt | Cowen | Outperform |
| 2019-09-26 | Hochstufung | Citigroup | Neutral → Buy |
| 2019-08-20 | Hochstufung | Piper Jaffray | Neutral → Overweight |
| 2019-06-27 | Hochstufung | Wolfe Research | Underperform → Peer Perform |
| 2019-06-26 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2019-05-28 | Eingeleitet | Goldman | Neutral |
| 2019-04-29 | Hochstufung | BMO Capital Markets | Underperform → Market Perform |
Alle ansehen
Abbvie Inc Aktie (ABBV) Neueste Nachrichten
Got $1,500? 3 Healthcare Stocks to Buy and Hold Forever - Yahoo! Voices
Evolus, An AbbVie And Botox Rival, Just Hit The Stratosphere — Here's Why - Yahoo! Voices
AbbVie, Simcere Zaiming partner on myeloma treatment SIM0500 - Myeloma Research News
Zhang Financial LLC Buys 5,926 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Bought by Sky Investment Group LLC - MarketBeat
Guinness Asset Management LTD Increases Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Stokes Capital Advisors LLC Acquires 1,594 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
UMB Bank n.a. Decreases Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Community Bank of Raymore Has $2.47 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Corundum Group Inc. Acquires 4,159 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
3 Unstoppable Dividend-Growth Stocks Yielding More Than 3% That Income-Seeking Investors Want to Buy in 2025 and Hold Forever - The Motley Fool
United States Anesthesia Drugs Research Report 2025: A $3.67 Bn Market by 2033 with Competitive Analysis of Baxter, Abbvie, Medtronic, Draegerwerk, Koninklijke Philips, and Abbott Laboratories - Yahoo Finance
Acellular Dermal Matrices Market Is Booming Worldwide - openPR
AbbVie Inc. (ABBV): A Bull Case Theory - Insider Monkey
Diversify Wealth Management LLC Acquires 9,840 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Diversify Advisory Services LLC Sells 6,472 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Artemis Investment Management LLP Has $85.98 Million Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Brady Martz Wealth Solutions LLC Takes Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Ameritas Advisory Services LLC - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Bought by Wealth Alliance Advisory Group LLC - MarketBeat
Jackson Square Capital LLC Reduces Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Cohen Klingenstein LLC Reduces Stock Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Avanza Fonder AB Acquires Shares of 8,443 AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Short Interest Update - MarketBeat
Why Is AbbVie Inc. (ABBV) Among Louis Navellier’s Top Long-term Stock Picks? - Insider Monkey
AbbVie Inc. (NYSE:ABBV) Position Raised by Lake Street Private Wealth LLC - MarketBeat
AbbVie's SWOT analysis: stock outlook amid Humira erosion and pipeline growth - MSN
Brooklyn Investment Group Has $2.73 Million Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Householder Group Estate & Retirement Specialist LLC Reduces Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Wedge Capital Management L L P NC Trims Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Grant GrossMendelsohn LLC Sells 1,744 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Channel Wealth LLC Has $1.68 Million Stock Holdings in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie Inc. (NYSE:ABBV) Shares Purchased by Yarger Wealth Strategies LLC - MarketBeat
AbbVie Inc. (NYSE:ABBV) Stock Holdings Lifted by KMG Fiduciary Partners LLC - MarketBeat
Deal Dispatch: Biden Punts TikTok Ban To Trump, Plus Another Legacy Retailer Goes Bankrupt - Benzinga
Two more AbbVie drugs put on the Medicare negotiation list - Crain's Chicago Business
AbbVie (ABBV) Benefitted from Top-Line Growth From Its Immunosuppressive Drugs - MSN
Decker Retirement Planning Inc. Purchases New Position in AbbVie Inc. (NYSE:ABBV) - MarketBeat
AbbVie stock target cut, keeps Buy rating on growth outlook - Investing.com
FY2024 Earnings Forecast for AbbVie Issued By Zacks Research - MarketBeat
Tallon Kerry Patrick Buys New Shares in AbbVie Inc. (NYSE:ABBV) - MarketBeat
Mason & Associates Inc Acquires 1,499 Shares of AbbVie Inc. (NYSE:ABBV) - MarketBeat
Giant-Cell Arteritis Pipeline Update 2024: FDA Approvals, Therapeutic Advancements, MOA, ROA, and Developments | AbbVie, Novartis, CSL, Kiniksa Pharma, Eli Lilly, Roche, Johnson & Johnson, MorphoSys - Barchart
Why the Market Dipped But AbbVie (ABBV) Gained Today - Yahoo Finance
AbbVie Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
BMO maintains AbbVie stock Outperform rating - MSN
AbbVie's Quarterly Earnings Preview: What You Need to Know - Nasdaq
Humira Holds Firm at 72% Market Share-AbbVie Fends Off Biosimila - GuruFocus.com
AbbVie and Simcere Join Forces for Multiple Myeloma Breakthrough - Zenopa
Humira Holds Firm at 72% Market Share-AbbVie Fends Off Biosimilar Surge - Yahoo Finance
AbbVie retains Humira market share above 70%: report - MSN
Finanzdaten der Abbvie Inc-Aktie (ABBV)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.76%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):